The rise seen in the European stock market during the first half of the year levelled off over the summer, while the rally in China picked up speed. The US stock market gained new momentum on the back of higher expectations of rate cuts. We continue to overweight Europe in our regional recommendations, as we expect the economic recovery and strategic investments in the continent to boost corporate earnings growth.
Uncertainty abates
The markets concluded that a bad deal is better than no deal, when the EU, Japan and Korea, among others, reached trade deals with the US at the end of the summer. Companies like shipping giant Mærsk expect lower uncertainty to facilitate decision-making and boost global trade after a challenging spring. In August, Mærsk revised its view of global container volume growth, now expecting it to be in the range of 2% to 4%.
Tariffs will undoubtedly have an impact on business profitability, with the US government collecting 10% to 50% of the import value of imported goods, depending on the product. Pricing power will determine how costs are distributed in the production chain. For the most part, the effects of tariffs will remain moderate, but the highest rates will put an end to some trade relations, forcing countries to search for new partners. The leaders of the largest emerging countries have already decided to strengthen their mutual trade relations due to the high tariffs and unpredictable policies introduced by the US, while the EU aims to strengthen its internal market.
The 15% import tariff imposed by the US on the EU is a fairly moderate rate, which didn’t weaken the EU’s competitiveness relative to other exporting countries. However, the appreciation of the euro adds another challenge for export companies. Despite these challenges, Europe’s recovery has continued, and economic growth is expected to pick up markedly next year, driven by lower interest rates and sizeable investment. We therefore recommend overweighting European equities due to their moderate valuations and improving earnings growth.
Stocks rally in China
The trade negotiations between China and the US were extended again in August, but the continued uncertainty has not been reflected in the Chinese stock market, which saw a strong rise in the summer. The Shanghai Stock Exchange, which is dominated by local investors, rose to its highest value in 10 years at the end of August. Share prices also saw a steep rise on the Hong Kong Stock Exchange, where it is easier for foreign investors to invest than in mainland China. Chinese households have accumulated significant savings, but investments have been scarce recently due to the weak housing market and low interest rates. As a result, households have begun to channel their savings into equities, which also seems to be the goal of the country’s political leaders. Favourable developments in the stock market make it easier for technology companies to list and raise funding. The promotion of technological self-sufficiency and innovation is now the number one priority for China.
A year ago, there was a lot of speculation in the markets about whether China is still fit for investment but this talk seems to have since died down. In the summer, the US investment bank Goldman Sachs introduced a list of Chinese companies poised for growth, calling it the ‘Prominent 10’ in the same vein as the ‘Magnificent 7’ US tech companies. The ‘Prominent 10’ includes China’s largest tech companies Tencent, Alibaba and Xiaomi, among others.
Technology and finance are the top gainers
The US stock market rally has been driven by large tech companies again this year, but the share prices of manufacturing companies and companies providing public goods have also risen strongly. The healthcare sector has performed the weakest out of all major sectors, suffering from the Trump administration’s cuts to Medicaid and research funding, as well as demands to lower drug prices. In Europe, the rise in share prices has been driven by banks, public goods and the defence sector. The weakest performance has come from the consumer sector, including car companies suffering from tariffs and luxury goods companies weighed down by lower demand.

We continue to have confidence in the financial sector and are keeping it overweight, as loan volumes have started to grow, investment banking has picked up and de-regulation is at least being considered. Intriguing opportunities may also open up in the materials sector, where a significant turnaround in earnings is expected next year, or in health care, provided that the political pressure on the sector eases. Valuations in the health care sector relative to long-term earnings growth are now clearly lower than in the past 20 years.